Jazz Pharmaceuticals plc
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters are located in Dublin, Ireland, and our U.S. operations are located in Palo Alto, California, Carlsbad, California, Philadelphia, Pennsylvania and Durham, North Carolina. In addition to our owned manufacturing and development facilities and our leased administrative, manufacturing and development facilities, we also have dedicated growing facilities operated by contract partners. The following table contains information about our significant properties as of December 31, 2025:
| Type | Location | Approximate Square Feet | Lease / Contract Expiration Date |
|---|---|---|---|
| Administrative office | Dublin, Ireland | 45,000 | 2036 |
| Administrative office | Palo Alto, U.S. | 27,000 | 2035 |
| Administrative office | Philadelphia, U.S. | 60,000 | 2029 |
| Administrative office | Carlsbad, U.S. | 43,000 | 2028 |
| Administrative office and laboratory | Durham, U.S. | 29,000 | 2026 |
| Administrative office | Cambridge, U.K. | 22,000 | 2026-2030 |
| Administrative office and laboratory | Vancouver, Canada | 15,000 | 2029 |
| Administrative office | London, U.K. | 13,000 | 2034 |
| Administrative office and laboratory | Villa Guardia (Como), Italy | 34,000 | 2029 |
| Manufacturing and development | Athlone, Ireland | 58,000 | Owned |
| Manufacturing and development | Southern U.K. | 136,000 | 2026-2036 |
| Manufacturing and development | Villa Guardia (Como), Italy | 45,000 | Owned |
| Growing facility | Eastern U.K. | 1,960,000 | 2031 |
| Growing facility | Northern U.K. | 915,000 | 2030 |
In addition, we have offices in Japan, Australia, France and elsewhere in Europe.
We believe that our existing properties are in good condition and suitable for the conduct of our business. As we continue to expand our operations, we may need to lease additional or alternative facilities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.